Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
Deficiencies identified by the US Food and Drug Administration (FDA) at Icelandic biosimilar firm Alvotech’s Reyjkavik facility have results in a second complet 30 June 2023
Medicines for Europe has said that it sees the revision of European Union (EU) pharmaceutical legislation as an opportunity to accelerate patient access to safe 15 June 2023
Generics and biosimilar medicines company Sandoz has trumpeted the launch of what it calls a ‘global roadmap to increase patient access to biologic medicines’. 15 June 2023
Sandoz, the generics unit of Novartis, has outlined an ambitious plan for its newly-independent future once the spin-out from its parent is complete. 9 June 2023